Given its non-invasive nature, there is increasing interest in the use of transcutaneous vagus
nerve stimulation (tVNS) across basic, translational and clinical research …

Cognitive dysfunction in Alzheimer's disease (AD) is caused by disturbances in neuronal
circuits of the brain underpinned by synapse loss, neuronal dysfunction and neuronal death …

Vagus nerve stimulation (VNS) is widely used to treat drug-resistant epilepsy and
depression. While the precise mechanisms mediating its long-term therapeutic effects are …

Transcutaneous auricular vagus nerve stimulation (taVNS) has been proposed to activate
the locus ceruleus-noradrenaline (LC-NA) system. However, previous studies failed to find …

Non‐invasive brain stimulation techniques, such as transcutaneous auricular vagus nerve
stimulation (taVNS), have considerable potential for clinical use. Beneficial effects of taVNS …

Transcutaneous vagus nerve stimulation (tVNS) is a non‐invasive neurostimulation
technique that is currently being tested as a potential treatment for a myriad of neurological …

The COVID-19 pandemic has led to widespread increases in mental health problems,
including anxiety and depression. The development of these and other psychiatric disorders …

Transcutaneous auricular vagus nerve stimulation (taVNS) is a neurostimulatory technique
hypothesised to enhance central noradrenaline. Currently, there is scarce evidence in …

Vagus nerve stimulation (VNS) is thought to affect neural activity by recruiting brain-wide
release of neuromodulators. VNS is used in treatment-resistant epilepsy, and is increasingly …

Brain stimulation approaches are important to gain causal mechanistic insights into the
relevance of functional brain regions and/or neurophysiological systems for human cognitive …